StonvexLoading…
StonvexCore line items from VG's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $4.60B | $13.77B | $9.32B | $6.00B |
Operating Income | $1.15B | $5.16B | $3.44B | $2.12B |
Net Income | $625.00M | $2.73B | $1.54B | $992.00M |
EPS (Diluted) | $0.19 | $0.86 | $0.45 | $0.29 |
Total Assets | $56.30B | $53.45B | $50.08B | $46.51B |
Total Liabilities | $43.95B | $41.45B | $39.26B | $36.10B |
Cash & Equivalents | $1.60B | $2.35B | $1.88B | $2.25B |
Free Cash Flow OCF − CapEx | $-2.42B | $-6.80B | $-5.29B | $-3.87B |
Shares Outstanding | 2.63B | 2.63B | 2.64B | 2.64B |